TPG, a leading global alternative asset firm, announced on Monday it has secured a majority investment in iNova Pharmaceuticals, an independent consumer healthcare and medicine products company.
“Our investment in iNova is timed as the world emerges from COVID-19 pandemic and consumers are increasingly mindful of preventative and early treatment across a range of symptoms, particularly upper respiratory, cold and flu,”…